India, Aug. 13 -- New Delhi | August 2026 For thousands of Indian families, a diagnosis of prostate cancer brings fear, uncertainty and difficult decisions. For many men-particularly those diagnosed while still professionally active and supporting their families-the greatest concern is often not cancer alone, but whether treatment will permanently affect urinary control, sexual function, independence and overall quality of life.

A landmark international clinical study, together with scientific discussions at SOGOCON 2026, is now providing encouraging long-term evidence that, for carefully selected patients, organ-preserving focal High-Intensity Focused Ultrasound (HIFU) can effectively control localized prostate cancer while preserving q...